Proteomic cancer biomarkers from discovery to approval: it's worth the effort.

@article{Li2014ProteomicCB,
  title={Proteomic cancer biomarkers from discovery to approval: it's worth the effort.},
  author={Danni Li and Daniel Wai-Tin Chan},
  journal={Expert review of proteomics},
  year={2014},
  volume={11 2},
  pages={135-6}
}
The current landscape of cancer biomarkers is changing rapidly, with new and exciting developments. With the advances of proteomic technologies, many potential cancer biomarkers have been discovered. However, the number of new cancer biomarkers cleared or approved by the US FDA is rather limited. Although technological advances are important, clearly defining intended use, good study design and appropriate patient specimens are critical for the success of FDA approval. While obtaining FDA… CONTINUE READING
Highly Cited
This paper has 18 citations. REVIEW CITATIONS